FIV and FeLV in Cats: Welfare Considerations
Feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) are major infectious diseases of cats with significant welfare implications. This page covers transmission, clinical progression, welfare management, and quality of life.
Overview of FIV and FeLV
FIV (feline immunodeficiency virus) is a lentivirus causing progressive immune suppression in cats, analogous to HIV in humans. FeLV (feline leukaemia virus) is a gammaretrovirus causing immunosuppression, anaemia, and lymphoma. Both are transmitted between cats: FIV primarily via bite wounds, FeLV via mutual grooming, shared food/water bowls, and between mothers and kittens. Both are globally prevalent in free-roaming cat populations.
Clinical Progression and Welfare Implications
FIV-positive cats may live for years—even decades—with minimal symptoms during the asymptomatic phase. Welfare declines as secondary infections (oral disease, skin infections, respiratory illness) accumulate due to immunosuppression. FeLV has a more variable prognosis: some cats regress to a latent state, others progress to severe immunosuppression, anaemia, or lymphoma within months to years. Secondary disease causes significant suffering—weight loss, pain, lethargy, dyspnoea.
Testing and Early Detection
PCR and ELISA testing allows early identification. Welfare benefits of testing include: allowing early intervention for secondary infections, informing housing decisions (indoor-only status to prevent spread), and enabling owner preparation for disease progression. All rescue cats should be tested. FeLV testing at 30 days and again at 60 days after potential exposure is recommended to account for the window period.
Indoor Management and Social Housing
FIV-positive cats can live with FeLV-negative cats if all are non-aggressive, as FIV is not efficiently spread via shared environment. FeLV-positive cats ideally require separate housing to prevent transmission. However, welfare concerns around isolation—loneliness, reduced enrichment—must be weighed. Stable groups of FeLV-positive cats can be housed together. Single FIV cats benefit from the same enrichment, play, and social contact as any indoor cat.
Managing Secondary Illness
Active welfare management involves prompt treatment of secondary infections: dental disease, upper respiratory infections, skin conditions, and opportunistic organisms. Anti-viral therapies (interferon-omega, antiviral drugs) have limited evidence but may reduce secondary infection burden. Nutritional support, pain management for oral disease, and regular veterinary monitoring are core welfare interventions. Stress—which worsens immunosuppression—should be minimised.
End-of-Life Welfare
Disease progression eventually impairs quality of life. Indicators for palliative care or euthanasia include: inability to eat without pain, severe dyspnoea, uncontrolled secondary infections, or signs of lymphoma-associated distress. Quality-of-life assessment tools (HHHHHMM scale, Cincinnati protocol) provide structured frameworks for these decisions. Owners benefit from early conversations about disease trajectory and end-of-life expectations.
Positive Welfare in FIV/FeLV Cats
Positive welfare—not just absence of suffering—is achievable for FIV and many FeLV cats. Enriched indoor environments, stable social groups, predictable routines, and attentive owners enable good psychological wellbeing throughout much of the disease course. Many FIV-positive cats live normal, full lives. Welfare management should be framed around enabling positive experiences, not solely managing decline.
Summary
FIV and FeLV require informed management to optimise welfare. FIV-positive cats can live well for many years with appropriate indoor management, monitoring, and prompt secondary infection treatment. FeLV prognosis is more variable but positive welfare remains achievable for extended periods. Welfare frameworks should address both physical health management and psychological wellbeing for these cats.